From 06.09.2021 to 10.09 2021, representatives of the State Service of Ukraine for Medicines and Drug Control audited the production of medicines at the place of business. Firm “Novofarm-Biosyntez” LLC passed the audit without critical reservation. During the audit, representatives of the state regulatory body assessed all aspects of the Company’s activities within the GMP requirements.
On 24.11.2021, the State Medical Service of Ukraine issued a GMP certificate based on the audit results. This certificate confirms that the current state of production of medicines produced at the Company’s sites meets the requirements of the Guidelines ST-N MOZU 42-4.0: 2020 “Medicines. Good Manufacturing Practice”.